Table 1 Demographics. tumor and treatment characteristics
n = 335 | |
|---|---|
Male sex | 290 (87%) |
Age (yrs) | 62 [30 - 90] |
BMI (kg/m2) | 24.5 [14.6 – 45.9] |
ASA score | |
1 | 10 (3%) |
2 | 183 (55%) |
3 | 137 (41%) |
4 | 5 (2%) |
Multimodal therapy | |
None | 73 (22%) |
Neoadjuvant radiochemotherapy | 189 (56%) |
Perioperative chemotherapy | 73 (22%) |
Tumor localisation | |
Upper third | 14 (4%) |
Middle third | 72 (22%) |
Lower third/junctional tumor | 249 (74 %) |
Surgical approach | |
Thoracoabdominal | 309 (92%) |
Transhiatal | 26 (8%) |
Reconstruction | |
Gastric tube | 321 (96%) |
Colon interposition | 14 (4%) |
Anastomosis | |
Intrathoracic | 185 (55%) |
Cervical | 150 (45%) |
Tumor histological type | |
Squamous cell carcinoma | 137 (41%) |
Adenocarcinoma | 198 (59%) |
UICC-Stage | |
0/1 | 111 (33%) |
2 | 140 (42%) |
3 | 63 (19%) |
4 | 21 (6%) |
Resection margin | |
R0 | 316 (94%) |
R+ | 19 (6%) |
Median operating time (min) | 420 [203 - 906] |
Median ICU stay (days) | 8 [1 - 121] |
Median Hospital stay (days) | 22 [3 - 150] |